18.50Open18.50Pre Close0 Volume3 Open Interest59.00Strike Price0.00Turnover9648.66%IV0.40%PremiumDec 13, 2024Expiry Date18.19Intrinsic Value100Multiplier0DDays to Expiry0.31Extrinsic Value100Contract SizeAmericanOptions Type0.9439Delta0.0082Gamma4.26Leverage Ratio-599.6794Theta0.0000Rho4.02Eff Leverage0.0002Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet